Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...
Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...
Hyderabad, India – March 12, 2013 – Neuland Laboratories Ltd., (NSE:NEULANDLAB; BOM:524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...
Bristol-Myers Squibb (BMS) has agreed to sell its small-molecule active pharmaceutical ingredient (API) manufacturing facility in Swords, Ireland, to Seoul, South Korea-based contract development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback